Pacific Capital Partners’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,282
Closed -$648K 56
2024
Q3
$648K Hold
15,282
0.38% 50
2024
Q2
$616K Hold
15,282
0.41% 54
2024
Q1
$541K Hold
15,282
0.35% 56
2023
Q4
$452K Buy
15,282
+277
+2% +$5.75K 0.34% 55
2023
Q3
$312K Buy
+15,005
New +$412K 0.19% 58

Other funds holding TNDM

Pacific Capital Partners's TNDM Position: Q4 2024 in Review

Pacific Capital Partners sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 15,282 shares — an estimated $648K sold.

Pacific Capital Partners first reported a position in TNDM in Q3 2023 and held it in 5 quarters. The position peaked at $648K in Q3 2024. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

  • Pacific Capital Partners reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
  • Pacific Capital Partners sold 15,282 Tandem Diabetes Care shares in Q4 2024, an estimated $648K.
  • Pacific Capital Partners first reported a position in Tandem Diabetes Care in Q3 2023 and held it in 5 quarters.
  • Pacific Capital Partners's Tandem Diabetes Care position peaked at $648K in Q3 2024.
  • 316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on Pacific Capital Partners's 13F filing for Q4 2024, filed 8 May 2025.